Antimalarial Drug Susceptibility Testing of Plasmodium Falciparum in Thailand Using a Microdilution Radioisotope Method

H. Kyle Webster U.S. Army Medical Component, AFRIMS, Rajavithi Road, Bangkok, Thailand

Search for other papers by H. Kyle Webster in
Current site
Google Scholar
PubMed
Close
,
Ellen F. Boudreau U.S. Army Medical Component, AFRIMS, Rajavithi Road, Bangkok, Thailand

Search for other papers by Ellen F. Boudreau in
Current site
Google Scholar
PubMed
Close
,
Katchrinnee Pavanand U.S. Army Medical Component, AFRIMS, Rajavithi Road, Bangkok, Thailand

Search for other papers by Katchrinnee Pavanand in
Current site
Google Scholar
PubMed
Close
,
Kosol Yongvanitchit U.S. Army Medical Component, AFRIMS, Rajavithi Road, Bangkok, Thailand

Search for other papers by Kosol Yongvanitchit in
Current site
Google Scholar
PubMed
Close
, and
Lorrin W. Pang U.S. Army Medical Component, AFRIMS, Rajavithi Road, Bangkok, Thailand

Search for other papers by Lorrin W. Pang in
Current site
Google Scholar
PubMed
Close
Restricted access

Antimalarial activity of chloroquine, quinine, mefloquine and halofantrine against 33 strains of P. falciparum isolated from naturally acquired malaria infections in Thailand was determined using a radioisotope microdilution method. A microtitration procedure was used to test isolates of P. falciparum against the 4 drugs simultaneously. The mean ID50 for chloroquine and quinine reflected known resistance to those drugs in Thailand. The mean ID50 for mefloquine and halofantrine showed susceptibility to these drugs. Four isolates of P. falciparum however had markedly decreased susceptibility to melfloquine (ID50 > 15 ng/ml); one case of which was confirmed as the first case of RII resistance for mefloquine in Thailand. Several parasite isolates were also observed to have decreased susceptibility to the new drug, halofantrine. These studies strongly recommend that in vitro testing be done in conjunction with field evaluation of new antimalarial drugs.

Author Notes

Save